These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 430039)

  • 21. Biochemical characterization of the dopaminergic innervation of the rat septum.
    Collu R; Stefanini E; Vernaleone F; Marchisio AM; Devoto P; Argiolas A
    Life Sci; 1980 May; 26(20):1665-73. PubMed ID: 7392803
    [No Abstract]   [Full Text] [Related]  

  • 22. Guanine nucleotides distinguish between two dopamine receptors.
    Creese I; Usdin T; Snyder SH
    Nature; 1979 Apr; 278(5704):577-8. PubMed ID: 431724
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of 3H-spiperone binding in caudate nuclei of rabbits and rats.
    Hernandez LL; Powell DA
    Pharmacol Biochem Behav; 1987 Feb; 26(2):253-8. PubMed ID: 3575350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible relationship between glial cells, dopamine and the effects of antipsychotic drugs.
    Henn FA; Anderson DJ; Sellström A
    Nature; 1977 Apr; 266(5603):637-8. PubMed ID: 859629
    [No Abstract]   [Full Text] [Related]  

  • 25. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
    Hamblin MW; Creese I
    Mol Pharmacol; 1982 Jan; 21(1):44-51. PubMed ID: 6127621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiparkinsonian drug doses and neuroleptic receptors.
    Titeler M; Seeman P
    Experientia; 1978 Nov; 34(11):1490-2. PubMed ID: 720482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [3H]Spiperone labels non-cyclase-linked dopamine receptors in the ventral tegmental area of rat brain.
    Gundlach AL; McDonald D; Beart PM
    J Neurochem; 1982 Sep; 39(3):890-4. PubMed ID: 7097294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of [3H]apomorphine to an aporphine binding site as well as to dopamine sites in tissue from bovine caudate nucleus.
    Arana GW; Lamont JS; Baldessarini RJ; Teicher MH; Neumeyer JL; Cohen BM
    Neuropharmacology; 1984 Aug; 23(8):885-92. PubMed ID: 6483116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum.
    Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
    Eur J Pharmacol; 1979 Oct; 58(3):341-2. PubMed ID: 510367
    [No Abstract]   [Full Text] [Related]  

  • 30. Investigations concerning the cellular origin of dopamine receptors.
    Henn FA; Titeler M; Anderson DJ; May K
    Life Sci; 1978 Aug; 23(6):617-21. PubMed ID: 692285
    [No Abstract]   [Full Text] [Related]  

  • 31. Stimulation by ATP of [3H]dopamine binding to synaptic membrane fractions of canine caudate nucleus.
    Sano K; Maeno H
    Biochem Biophys Res Commun; 1976 Dec; 73(3):584-90. PubMed ID: 1008875
    [No Abstract]   [Full Text] [Related]  

  • 32. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reconstitution of solubilised brain D2 dopamine receptors into phospholipid vesicles.
    Wheatley M; Strange PG
    FEBS Lett; 1984 Jan; 166(2):389-92. PubMed ID: 6229421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hallucinogen binding to dopamine/neuroleptic receptors.
    Whitaker PM; Seeman P
    J Pharm Pharmacol; 1977 Aug; 29(8):506-7. PubMed ID: 19605
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of lead exposure on dopaminergic receptors in rat striatum and nucleus accumbens.
    Govoni S; Lucchi L; Missale C; Memo M; Spano PF; Trabucchi M
    Brain Res; 1986 Aug; 381(1):138-42. PubMed ID: 3756492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of [3H]spiperone for labelling dopaminergic and serotonergic receptors in bovine caudate nucleus.
    Withy RM; Mayer RJ; Strange PG
    J Neurochem; 1981 Nov; 37(5):1144-54. PubMed ID: 7299393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irreversible blockade of [3H]spiperone- but not [3H]dopamine-labeled dopamine receptors with phenoxybenzamine.
    Titeler M
    Biochem Pharmacol; 1981 Nov; 30(22):3031-7. PubMed ID: 7337719
    [No Abstract]   [Full Text] [Related]  

  • 38. D2- but not D3-dopamine receptors detected in the anterior pituitary.
    Titeler M; Van Loon GR; Seeman P; Brown GM
    Eur J Pharmacol; 1981 Apr; 71(1):143-6. PubMed ID: 7238583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [3H]N-propylapomorphine and [3H]spiperone binding in brain indicate two states of the D2-dopamine receptor.
    Battaglia G; Titeler M
    Eur J Pharmacol; 1982 Jul; 81(3):493-8. PubMed ID: 6126376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine receptor topography. Characterization of antagonist requirements of striatal dopamine-sensitive adenylate cyclase using protoberberine alkaloids.
    Clement-Cormier YC; Meyerson LR; Phillips H; Davis VE
    Biochem Pharmacol; 1979 Oct; 28(20):3123-9. PubMed ID: 518711
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.